|
MORF4L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10219999996486E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.400940E-04 |
| Normal-vs-Stage2 |
3.50749999999955E-05 |
| Normal-vs-Stage3 |
9.69739999999719E-05 |
| Normal-vs-Stage4 |
1.98489999999607E-05 |
| Stage1-vs-Stage2 |
2.601600E-02 |
| Stage1-vs-Stage3 |
4.344000E-01 |
| Stage1-vs-Stage4 |
1.133970E-01 |
| Stage2-vs-Stage3 |
1.292760E-01 |
| Stage2-vs-Stage4 |
4.302800E-01 |
| Stage3-vs-Stage4 |
4.648400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52859999996902E-06 |
| Normal-vs-AfricanAmerican |
3.272600E-01 |
| Normal-vs-Asian |
4.056400E-02 |
| Caucasian-vs-AfricanAmerican |
8.880500E-02 |
| Caucasian-vs-Asian |
1.767770E-01 |
| AfricanAmerican-vs-Asian |
5.247600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23030000041136E-07 |
| Normal-vs-Female |
3.67869999999826E-05 |
| Male-vs-Female |
1.187950E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.755400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.003590E-04 |
| Normal-vs-Age(61-80Yrs) |
8.15270000398272E-08 |
| Normal-vs-Age(81-100Yrs) |
4.676400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.397400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.935500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.653600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.979830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.719000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.349200E-01 |
| Classical-VS-Follicular |
4.72419999997253E-06 |
| Classical-VS-Other |
1.188580E-01 |
| Classical-VS-Normal |
9.742100E-03 |
| Tall-VS-Follicular |
1.501800E-02 |
| Tall-VS-Other |
4.685400E-01 |
| Tall-VS-Normal |
3.623100E-03 |
| Follicular-VS-Other |
8.336000E-01 |
| Follicular-VS-Normal |
9.49790002202633E-09 |
| Other-VS-Normal |
9.919800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80249999984328E-07 |
| Normal-vs-N1 |
3.82190000003391E-06 |
| N0-vs-N1 |
4.258400E-01 |
|
|
